Is there still a role for interferon-alpha for newly diagnosed chronic myeloid leukemia in chronic phase?
作者信息
Quintás-Cardama Alfonso, Verstovsek Srdan
机构信息
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
出版信息
Leuk Lymphoma. 2007 Mar;48(3):445-6. doi: 10.1080/10428190701217087.
PMID:17454579
Abstract
摘要
相似文献
1
Is there still a role for interferon-alpha for newly diagnosed chronic myeloid leukemia in chronic phase?
Leuk Lymphoma. 2007 Mar;48(3):445-6. doi: 10.1080/10428190701217087.
2
Pregnancy in chronic myeloid leukemia patients treated with alpha interferon.
Int J Gynaecol Obstet. 2004 Jun;85(3):281-2. doi: 10.1016/j.ijgo.2003.11.014.
3
Interferon-alpha lymphoblastoid in chronic myeloid leukemia patients unresponsive to recombinant IFN alpha 2.α干扰素淋巴母细胞样制剂用于对重组α干扰素2无反应的慢性髓性白血病患者。
Haematologica. 1997 Nov-Dec;82(6):731-2.
4
Juvenile chronic myelogenous leukemia: therapeutic trial with interferon alpha 2B.青少年慢性粒细胞白血病：干扰素α-2B治疗试验
Indian Pediatr. 1995 Sep;32(9):1002-4.
5
6
The interferon-alpha revival in CML.慢性粒细胞白血病中α干扰素的复兴
Ann Hematol. 2015 Apr;94 Suppl 2:S195-207. doi: 10.1007/s00277-015-2326-y. Epub 2015 Mar 27.
7
Bone marrow necrosis masquerading as interferon toxicity in chronic myeloid leukemia.慢性髓性白血病中伪装成干扰素毒性的骨髓坏死
Leuk Lymphoma. 1999 Apr;33(3-4):385-8. doi: 10.3109/10428199909058440.
8
[Treatment with interferon alpha of the lymphoblastic transformation of chronic myeloid leukemia].
Sangre (Barc). 1999 Dec;44(6):493-4.
9
Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia.新诊断慢性髓性白血病患者对伊马替尼或干扰素α加阿糖胞苷产生主要分子反应的频率。
N Engl J Med. 2003 Oct 9;349(15):1423-32. doi: 10.1056/NEJMoa030513.
10
Therapy of chronic myelogenous leukemia.慢性粒细胞白血病的治疗
Cancer. 1987 Feb 1;59(3 Suppl):664-7. doi: 10.1002/1097-0142(19870201)59:3+<664::aid-cncr2820591316>3.0.co;2-y.
Zotero 插件